Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: The excellent (efficacy of Xience/Promus versus cypher to reduce late loss after stenting) randomized trial

Journal of the American College of Cardiology

Volumn 58, Issue 18, 2011, Pages 1844-1854

  Park, Kyung Woo ^a   Chae, In Ho ^b   Lim, Do Sun ^c   Han, Kyoo Rok ^d   Yang, Han Mo ^a   Lee, Hae Young ^a   Kang, Hyun Jae ^a   Koo, Bon Kwon ^a   Ahn, Taehoon ^e   Yoon, Jung Han ^f   Jeong, Myung Ho ^g   Hong, Taek Jong ^h   Chung, Woo Young ⁱ   Jo, Sang Ho ^j   Choi, Young Jin ^j   Hur, Seung Ho ^k   Kwon, Hyuck Moon ^l   Jeon, Dong Woon ^m   Kim, Byung Ok ⁿ   Park, Si Hoon ^o   Lee, Nam Ho ^p   Jeon, Hui Kyung ^q   Gwon, Hyeon Cheol ^r   Jang, Yang Soo ^s   Kim, Hyo Soo ^a   more..

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Kangdong Sacred Heart Hospital   (South Korea)

^e Gachon University College of Medicine   (South Korea)

^f Yonsei University Wonju   (South Korea)

^g Chonnam National University Medical School   (South Korea)

^h Pusan National University Hospital   (South Korea)

ⁱ Seoul National University Boramae Hospital   (South Korea)

^j Hallym University   (South Korea)

^k Keimyung University   (South Korea)

^l Yonsei University College of Medicine   (South Korea)

^m National Health Insurance Corporation   (South Korea)

ⁿ Inje University College of Medicine   (South Korea)

^o Mokdong Hospital   (South Korea)

^p Kangnam Sacred Heart Hospital   (South Korea)

^q Uijeongbu St Mary's Hospital   (South Korea)

^r Sungkyunkwan University   (South Korea)

^s Yonsei University College of Medicine   (South Korea)

more..

Author keywords

everolimus; percutaneous coronary intervention; sirolimus; stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; RAPAMYCIN;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORONARY ARTERY PERFORATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOINTIMA; OPEN STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS; THERAPY EFFECT; TREATMENT DURATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; SIROLIMUS;

EID: 80055015153     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.07.031     Document Type: Article

References (24)

1. R.A. Costa, A.J. Lansky, and G.S. Mintz Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial) Am J Cardiol 95 2005 113 116 (Pubitemid 40051124)
2. P.W. Serruys, P. Ruygrok, and J. Neuzner A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
3. G.W. Stone, M. Midei, and W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913 (Pubitemid 351574920)
4. G.W. Stone, A. Rizvi, and W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
5. E. Kedhi, K.S. Joesoef, and E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
6. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662 (Pubitemid 41175673)
7. A. Dibra, A. Kastrati, and J. Mehilli Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670 (Pubitemid 41175674)
8. J.J. Goy, J.C. Stauffer, M. Siegenthaler, A. Benoit, and C. Seydoux A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial J Am Coll Cardiol 45 2005 308 311 (Pubitemid 40094742)
9. M.C. Morice, A. Colombo, and B. Meier Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial JAMA 295 2006 895 904
10. A. Kastrati, A. Dibra, and S. Eberle Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials JAMA 294 2005 819 825 (Pubitemid 41175725)
11. D.W. Park, Y.H. Kim, and S.C. Yun Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent with Sirolimus-Eluting and PacliTaxel-Eluting Stent for Coronary Lesions) randomized trial J Am Coll Cardiol 56 2010 1187 1195
12. K. Rasmussen, M. Maeng, and A. Kaltoft Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial Lancet 375 2010 1090 1099
13. K.W. Park, J.H. Yoon, and J.S. Kim Efficacy of Xience/promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) trial: study design and rationale of a Korean multicenter prospective randomized trial Am Heart J 157 2009 811 817.e1
14. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
15. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
16. J. Schofer, M. Schluter, and A.H. Gershlick Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099 (Pubitemid 37222332)
17. E. Schampaert, E.A. Cohen, and M. Schluter The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 2004 1110 1115 (Pubitemid 38352997)
18. B. Nashan Review of the proliferation inhibitor everolimus Expert Opin Investig Drugs 11 2002 1845 1857
19. A.J. Carter, A. Brodeur, and R. Collingwood Experimental efficacy of an everolimus eluting cobalt chromium stent Catheter Cardiovasc Interv 68 2006 97 103 (Pubitemid 44024469)
20. M.C. Morice, P.W. Serruys, and P. Barragan Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial J Am Coll Cardiol 50 2007 1299 1304 (Pubitemid 47454687)
21. G. Weisz, M.B. Leon, and D.R. Holmes Jr. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial J Am Coll Cardiol 53 2009 1488 1497
22. L.O. Jensen, P. Thayssen, and H.S. Hansen A prospective, randomized trial of everolimus-eluting and sirolimus-eluting stents in patients with coronary artery disease: the SORT OUT IV trial Paper presented at: Transcatheter Cardiovascular Therapeutics Annual Meeting as a Late Breaking Clinical Trial September 24, 2010 Washington, DC
23. R.A. Byrne, A. Kastrati, and K. Tiroch Two-year outcomes after everolimus- or sirolimus-eluting stents in patients with coronary artery disease in the ISAR-TEST 4 trial Paper presented at: Transcatheter Cardiovascular Therapeutics Annual Meeting as a Late Breaking Clinical Trial, September 24 2010 Washington, DC
24. Y. Nakagawa, T. Kimura, and T. Morimoto Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry) Am J Cardiol 106 2010 329 336